PharmaIN Competitors and Similar CompaniesClear all
PharmaIN's competitors and similar companies include NanoMedical Systems, Kymera Therapeutics and Praxis Precision Medicines.
 NanoMedical Systems NanoMedical Systems is a company focused on the commercialization of medical nanotechnology products. |  Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases. |  Praxis Precision Medicines Praxis Precision Medicines is a company that develops therapies intended for patients and families affected by complex and debilitating brain disorders. | ||
Founding Date | Founding Date 2000 | Founding Date 2007 | Founding Date 2017 | Founding Date 2015 |
Type | Type Private | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Bothell, US HQ | Locations Austin, US HQ | Locations Watertown, US HQ Cambridge, US | Locations Cambridge, US HQ |
Employees | Employees 23 | Employees 8 | Employees 207 | Employees 11641% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3.1 b | Valuation ($) 1.3 b |
Funding | ||||
Latest funding round | Latest funding round $ 1.5m (about 12 years ago) | Latest funding round $ 3m (almost 8 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 1.5m | Total funding raised $ 10.2m | Total funding raised $ 197m | Total funding raised $ 131.9m |
For sources of this data, please see the company profile
View Company Profiles
NanoMedical Systems
HQ
Austin, US
Employees
8
NanoMedical Systems is a company focused on the commercialization of medical nanotechnology products.
View companyKymera Therapeutics
HQ
Watertown, US
Employees
207
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
View companyPraxis Precision Medicines
HQ
Cambridge, US
Employees
116↑ 41% increase
Praxis Precision Medicines is a company that develops therapies intended for patients and families affected by complex and debilitating brain disorders.
View company